abstract |
The present invention relates to a kit comprising: (i) at least one dose of sulindac, or a pharmaceutically acceptable salt thereof; and (ii) at least one dose of Compound A, or a pharmaceutically acceptable salt thereof, for the treatment of fragile x syndrome. |